Actelion Pharmaceuticals Ltd - Company Profile
Powered by
All the data and insights you need on Actelion Pharmaceuticals Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Actelion Pharmaceuticals Ltd Strategy Report
- Understand Actelion Pharmaceuticals Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Actelion Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4056179A1 | Application | DOSIERSCHEMA FÜR PONESIMOD, EINEN SELEKTIVEN S1P1-REZEPTORAGONISTEN | A61K31/22; A61K31/225; A61K31/4015; A61K31/426; A61K9/0053; A61P1/00; A61P1/04; A61P11/02; A61P11/06; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P25/00; A61P25/28; A61P27/02; A61P29/00; A61P3/10; A61P35/00; A61P35/04; A61P37/02; A61P37/06; A61P37/08; A61P5/14 | September 14, 2022 |
WO2022180194A1 | Application | METHODS FOR TREATING PULMONARY HYPERTENSION IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION | A61K31/506 | September 01, 2022 |
US20220273623A1 | Application | METHODS OF TREATING MULTIPLE SCLEROSIS | A61K31/426; A61P25/28 | September 01, 2022 |
EP4048235A1 | Application | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT SELEXIPAG | A61K31/4965; A61K9/0053; A61K9/2013; A61K9/2018; A61K9/2054; A61K9/2059; A61P1/04; A61P11/00; A61P13/12; A61P17/02; A61P3/10; A61P43/00; A61P9/10; A61P9/12; A61P9/14 | August 31, 2022 |
ZA201507657B | Grant | PYRIDIN-4-YL DERIVATIVES | A61P1/04; A61P11/02; A61P11/06; A61P13/12; A61P17/06; A61P19/02; A61P25/00; A61P27/14; A61P29/00; A61P3/10; A61P35/00; A61P35/04; A61P37/00; A61P37/02; A61P37/06; A61P37/08; A61P5/14; C07D413/04 | August 31, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer